Dr Shaw received her medical degree from the University of Glasgow, and subsequently, Membership of the Royal College of Physicians. She held a Wellcome Trust Clinical Fellowship to investigate melanocyte (pigment cell) transformation and concurrently worked within the Royal Marsden Drug Development Unit on a number of early phase trials. Dr Shaw undertook specialty training at University College London Hospital and Mount Vernon Cancer Centre resulting in certification in medical oncology. She was recently appointed as a Consultant Medical Oncologist between University College London Hospital – to set up a systemic treatment service for melanoma with a focus on early phase trials and facilitating translational research for the condition; and to join the busy and dynamic Mount Vernon Cancer Centre Skin Cancer Service.
Dr Shaw’s main interests are the development of new strategies for treating melanoma including rare subtypes such as ocular, and combination therapies to overcome resistance to currently available treatments and maximise benefit for patients.